Lenka Besse

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 5

Top Venues

British journal of cancer

Cells

BJU international

This page only lists publications with an associated author ORCID identifier.

Publications

Andrej Besse, Lenka Sedlarikova, Lorina Buechler, Marianne Kraus, Chieh-Hsiang Yang, Nicol Strakova, Karel Souček, Jiri Navratil, Marek Svoboda, Alana L Welm, Markus Joerger, Christoph Driessen, Lenka Besse
HIV-protease inhibitors potentiate the activity of carfilzomib in triple-negative breast cancer. British journal of cancer 131 (5) (2024)
Andrej Besse, Lenka Sedlarikova, Lorina Buechler, Marianne Kraus, Chieh-Hsiang Yang, Nicol Strakova, Karel Souček, Jiri Navratil, Marek Svoboda, Alana L Welm, Markus Joerger, Christoph Driessen, Lenka Besse
HIV-protease inhibitors potentiate the activity of carfilzomib in triple-negative breast cancer. British journal of cancer (2024)
Andrej Besse, Marianne Kraus, Max Mendez-Lopez, Elmer Maurits, Herman S Overkleeft, Christoph Driessen, Lenka Besse
Immunoproteasome Activity in Chronic Lymphocytic Leukemia as a Target of the Immunoproteasome-Selective Inhibitors. Cells 11 (5) (2022)
Lenka Besse, Andrej Besse, Marianne Kraus, Elmer Maurits, Herman S Overkleeft, Beat C Bornhauser, Jean-Pierre Bourquin, Christoph Driessen
High Immunoproteasome Activity and sXBP1 in Pediatric Precursor B-ALL Predicts Sensitivity towards Proteasome Inhibitors. Cells 10 (11) (2021)
Dominik Abt, Andrej Besse, Lenka Sedlarikova, Marianne Kraus, Juergen Bader, Tobias Silzle, Martina Vodinska, Ondrej Slaby, Hans-Peter Schmid, Daniel Stephan Engeler, Christoph Driessen, Lenka Besse
Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir. BJU international 121 (4) (2017)

Lenka Besse.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Lenka Besse